{"id":1068528,"date":"2024-06-03T02:37:24","date_gmt":"2024-06-03T06:37:24","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/immutep-announces-clinical-collaboration-with-msd-to-evaluate-efti-in-combination-with-keytruda-pembrolizumab-in-pivotal-phase-iii-trial\/"},"modified":"2024-08-18T11:48:27","modified_gmt":"2024-08-18T15:48:27","slug":"immutep-announces-clinical-collaboration-with-msd-to-evaluate-efti-in-combination-with-keytruda-pembrolizumab-in-pivotal-phase-iii-trial","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/immutep-announces-clinical-collaboration-with-msd-to-evaluate-efti-in-combination-with-keytruda-pembrolizumab-in-pivotal-phase-iii-trial.php","title":{"rendered":"Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA\u00ae (pembrolizumab) in Pivotal Phase III Trial"},"content":{"rendered":"<p><![CDATA[SYDNEY, AUSTRALIA, June  03, 2024  (GLOBE NEWSWIRE) -- Immutep Limited\u00a0(ASX: IMM; NASDAQ: IMMP) (\u201cImmutep\u201d or \u201cthe Company\u201d), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announced that it has entered into a clinical trial collaboration and supply agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA), through a subsidiary, to evaluate eftilagimod alfa (efti) in combination with MSD\u2019s anti-PD-1 therapy, KEYTRUDA\u00ae (pembrolizumab) and chemotherapy for the first-line treatment of metastatic non-small cell lung cancer (NSCLC) in a pivotal Phase III trial.]]><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/06\/03\/2891872\/0\/en\/Immutep-Announces-Clinical-Collaboration-with-MSD-to-Evaluate-Efti-in-Combination-with-KEYTRUDA-pembrolizumab-in-Pivotal-Phase-III-Trial.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA\u00ae (pembrolizumab) in Pivotal Phase III Trial\">Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA\u00ae (pembrolizumab) in Pivotal Phase III Trial<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more: Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA\u00ae (pembrolizumab) in Pivotal Phase III Trial <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/immutep-announces-clinical-collaboration-with-msd-to-evaluate-efti-in-combination-with-keytruda-pembrolizumab-in-pivotal-phase-iii-trial.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068528","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068528"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068528"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068528\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}